Multifunctional Oral Hydrogel Containing Dual‐Active Pt/Mn3O4 Nanozyme for Synergistic Pyroptosis Suppression and Gut Microenvironment Reprogramming to Alleviate Radiation Intestinal Injury
Researchers have engineered an oral hydrogel, PMC@Gel, that co‑encapsulates a Pt/Mn3O4 nanozyme and curcumin to treat radiation‑induced intestinal injury. The nanozyme provides catalase‑ and SOD‑like activity, rapidly scavenging reactive oxygen species, while curcumin restores autophagy and modulates inflammation. The pH‑responsive alginate/hyaluronate matrix ensures intestinal release, strong mucosal adhesion, and prolonged retention. In animal models, PMC@Gel markedly reduced pyroptotic cell death, rebalanced gut microbiota, and accelerated epithelial repair.
Former FDA Deputies Land at Lilly, AbbVie; Italy's Angelini Has a New CEO
Eli Lilly and AbbVie have each hired former FDA deputy officials, with Karin Bok joining Lilly’s regulatory affairs team and an unnamed former FDA deputy moving to AbbVie’s drug‑development unit. The moves follow a broader trend of big pharma recruiting regulators to...
Monolithic Acoustic Droplet Centrifuge Array for Enhancing Point‐of‐Care Detection of Trace MicroRNAs
A monolithic acoustic droplet centrifuge array (SAWA) integrates nine miniaturized units on a 13 cm² chip, using a single surface‑acoustic‑wave activation to spin and analyze droplets in parallel. The platform enriches tumor cells and trace microRNAs within droplets, boosting fluorescence signal...
Biomimetic Multifunctional Scaffolds for Osteochondral Regeneration: Bridging Material Design and Functional Integration
The review outlines a systematic framework for engineering biomimetic osteochondral scaffolds, integrating four coordinated components: functional properties, bioactive material systems, advanced fabrication methods, and hierarchical structural designs ranging from monophasic to gradient configurations. By aligning these modules, researchers aim to...
Protein‐Capturing Microgel‐Integrated Microneedle Array Patches for Enhanced Tip‐Loading, Storage Stability, and Transdermal Delivery of Recombinant Proteins
Researchers introduced a microgel‑integrated microneedle array patch (MI‑MAP) that concentrates recombinant proteins at the needle tips and stabilizes them through phenolic interactions. Compared with conventional hydrogel‑based patches, MI‑MAP achieved markedly higher tip‑loading efficiency and maintained protein activity after 28 days at...
Breath-Based Testing Emerges as Tool for Monitoring Microbiome Health
Researchers at Washington University School of Medicine and the Children’s Hospital of Philadelphia demonstrated that volatile organic compounds (VOCs) in exhaled breath accurately reflect gut microbiome composition in children and gnotobiotic mice. By correlating breath VOC profiles with stool metagenomics,...
Mild Photothermal Stimulation Driven Nanoparticles Hybrid Dual‐Network Hydrogels for Bone Repair
The researchers present a PDA@GelMA/HA-DA/Fe3+ dual‑network hydrogel that combines gelatin methacryloyl, dopamine‑modified hyaluronic acid, Fe3+ crosslinking and polydopamine nanoparticles. Fe3+ ions act as angiogenic cues while the nanoparticles provide mild photothermal stimulation under near‑infrared light. In vitro, bone‑marrow mesenchymal stem...
Uncovering Two Key Enzymes in Tilianin Biosynthesis
Researchers have pinpointed two enzymes—flavonoid 3'-hydroxylase and a specific glycosyltransferase—that drive the final steps of tilianin biosynthesis in medicinal plants. The findings, published in a peer‑reviewed journal, map the enzymatic cascade and confirm the pathway’s regulatory nodes. By transferring these...
Ferroptosis in Cancer: Metabolism and Therapeutic Opportunities
Ferroptosis, an iron‑dependent form of regulated cell death, is gaining traction as a novel anticancer target. Recent research highlights how tumor metabolism—particularly iron overload and lipid peroxidation—creates vulnerabilities that can be exploited therapeutically. Agents that disrupt glutathione synthesis or block...
Breast Cancer’s Metabolic Weaknesses From Isozyme Loss
A recent study reveals that loss of specific metabolic isozymes creates exploitable weaknesses in breast cancer cells. Researchers identified that isozyme depletion disrupts glycolysis and oxidative phosphorylation, rendering tumors dependent on alternative pathways. Pre‑clinical models showed that targeting these compensatory...
Top 5 Trends that Will Drive Biopharma in the Next Decade with Tim Opler
Tim Opler, Managing Director at Stifel’s Global Healthcare Group, released his December 2025 Biopharma Market Update outlining five macro‑trends that will shape the industry over the next ten years. He highlights an accelerating M&A wave, the emergence of multi‑trillion‑dollar therapeutic markets...
Mendra Raises $82M in Series A Funding
Mendra, a San Francisco‑based biopharma focused on rare‑disease therapies, announced an $82 million Series A round. The financing was co‑led by OrbiMed, 8VC and 5AM Ventures, with Lux Capital and Wing VC also participating. The capital will fund the acquisition and development of...
Integrating Smartphone Apps in Alcohol Treatment: Clinician Insights
A recent study by Östh, Lundin and Wennberg surveyed clinicians on using smartphone app data in alcohol‑dependency treatment. The research found that practitioners value real‑time patient data for tailoring interventions and enhancing engagement, but cite technical glitches, privacy worries, and...
Novel Mouse Model for Gnaq p.R183Q Capillary Malformation
Researchers have introduced a genetically engineered mouse model carrying the Gnaq p.R183Q mutation, which replicates human capillary malformations. The model exhibits localized vascular ectasia, increased endothelial proliferation, and recapitulates the dermal phenotype seen in patients. Functional assays reveal hyperactive Gαq...
Stigmasterol Boosts Testicular and Sperm Function in Mice
Researchers at a leading biomedical institute reported that dietary stigmasterol markedly improves testicular health and sperm parameters in male mice. The study administered a 50 mg/kg oral dose for eight weeks, resulting in a 30% rise in sperm count and enhanced...
Unraveling Small-Cell Lung Cancer: A Multi-Omic Approach
Researchers performed an extensive multi‑omic analysis of small‑cell lung cancer, integrating genomics, transcriptomics, proteomics and metabolomics. The study identified several molecular subtypes with unique genetic mutations, expression signatures and metabolic profiles, and uncovered an immunosuppressive tumor microenvironment. Proteomic screening revealed...
III-Nitrides Enable Mini UV Spectral Imager
Researchers Zhao, Li, and Ooi have demonstrated a miniaturized ultraviolet spectral imager built on III‑nitride semiconductor technology. By integrating a dense array of GaN‑based photodetectors with on‑chip waveguides and nanoscale gratings, the device achieves benchtop‑level spectral resolution in a handheld...
Mapping Neurodevelopment in Preterm Infants Using Machine Learning
A multidisciplinary team applied deep‑learning algorithms to longitudinal MRI and EEG datasets from preterm infants, creating a predictive model of brain maturation. The model achieved over 85% accuracy in forecasting neurodevelopmental outcomes such as cognitive delay and cerebral palsy. By...
Neural Crest Cells Regulate Heart Development via Wnt
Researchers have uncovered that neural crest cells (NCCs) orchestrate heart formation by modulating the Wnt signaling cascade. Using genetically engineered mouse models, the team demonstrated that NCC‑derived Wnt ligands are essential for proper outflow‑tract alignment and septation. Disruption of Wnt...
Drones and Satellites Can Measure Methane Emissions From Ruminants
A multinational research team has demonstrated that drones equipped with methane sensors, combined with flux‑tower wind data and hyperspectral satellite imagery, can accurately quantify methane emissions from African livestock, including cattle, goats, sheep, and camels. Test flights in Norway and...
Endostatin’s Nuclear Transport Driven by Nucleolin in Endothelial Cells
Researchers have identified nucleolin as the primary carrier that shuttles endostatin into the nucleus of endothelial cells. The study demonstrates a direct binding interaction, enabling endostatin to modulate gene expression linked to angiogenesis. Nuclear localization of endostatin markedly reduces VEGF‑driven...
High‑MYC Tumors Evade the Immune System by Clearing R‑Loop Alarm Signals
Researchers published in Cell reveal that high‑MYC tumors evade immune detection by binding nascent RNA and clearing R‑loop structures that would otherwise trigger innate immune signaling. MYC multimerizes, forms condensates with the nuclear exosome, and uses its RBRIII RNA‑binding domain...
Plasma Proteomic Profiles of Elite HIV Controllers
Researchers analyzed plasma proteomes of elite HIV controllers, a rare group that naturally suppresses viral replication without therapy. Using high‑resolution mass spectrometry, they identified a distinct protein signature marked by lower inflammatory mediators and altered metabolic pathways. Comparative analysis with...
Ovarian Cancer Data Give Corcept’s Shares a Bounce After Year-End CRL Drop
Corcept Therapeutics reported positive Phase III results for relacorilant in platinum‑resistant ovarian cancer, meeting the overall survival endpoint. The data lifted the stock after a steep decline following a complete response letter that had cut the company's market value by half...
Corxel Draws $287M Round to Drive Global Development of Oral GLP-1
Corxel Pharmaceuticals announced a $287 million Series D‑1 financing round aimed at advancing its oral GLP‑1 therapy into late‑stage clinical trials. The capital will enable the company to move beyond its China‑only data and pursue a global development strategy. Existing backers RTW...
Association Between Maternal Infections During Pregnancy and Offspring Suicide Risk: A National Cohort Study
A nationwide Danish cohort study examined whether maternal infections during pregnancy raise the risk of suicide in offspring. Using linked health registers, the researchers identified over 1.2 million births and tracked maternal infection diagnoses alongside suicide outcomes up to age...
Astellas’ Okamura: The Bottleneck Isn’t Money — It’s Translation
Astellas CEO Naoki Okamura argues that Japan’s biotech sector is constrained more by the ability to translate scientific discoveries into market‑ready products than by a lack of capital. He outlines Astellas’ strategic focus on cell and gene therapies, a menopause...
Glucocorticoid Receptor Levels Link to Zebrafish Lateralization
Researchers have discovered that glucocorticoid receptor (GR) expression directly influences cerebral lateralization in zebrafish embryos. Using CRISPR‑mediated knock‑down and over‑expression assays, the team quantified asymmetrical gene‑expression patterns and behavioral turning bias. Zebrafish with elevated GR levels showed pronounced left‑right brain...
Doctors’ Views on AI Chatbots in Clinical Decisions
A recent survey of 1,200 physicians across the United States reveals that 68% view AI chatbots as useful adjuncts in clinical decision‑making, while 22% remain skeptical about their reliability. Doctors cite faster information retrieval and patient education as primary benefits,...
PRDM16 Expression: Key Prognostic Factor in AML
A new multi‑institutional study identifies high PRDM16 expression as a powerful prognostic marker in acute myeloid leukemia (AML). Analysis of over 500 patient transcriptomes shows that elevated PRDM16 correlates with significantly shorter overall survival and remains independent of established risk...
USP Develops Digital Quality Standards for Global Pharmaceutical Manufacturing
The United States Pharmacopeia (USP) is creating digital reference standards (dRS) and digitally structured compendial methods (dDS) to support digital‑first pharmaceutical workflows. These standards will be incorporated into the USP‑NF, allowing manufacturers to use machine‑readable data instead of physical materials....
Oligodendrocyte Differentiation Holds Promise for MS Treatment Development
Johns Hopkins researchers led by Dwight Bergles uncovered that oligodendrocyte precursor cells (OPCs) continuously differentiate into myelinating oligodendrocytes, a process they term constitutive differentiation. Using cross‑species gene‑expression profiling, protein localization, and live‑mouse time‑lapse microscopy, they identified distinctive “dandelion clock‑like” extracellular...
Predicting Post-Induction Hypotension in Elderly with Echocardiography
A recent study demonstrates that pre‑operative transthoracic echocardiography can reliably predict post‑induction hypotension (PIH) in patients over 65. Specific echo metrics, especially markers of diastolic dysfunction, showed strong correlation with intra‑operative blood pressure drops. The predictive model achieved over 80%...
Stingrays Inspire Smarter Ocean Robots: The Physics of Fin Motion
Researchers at the University of California, Riverside have built robotic fins that replicate stingray swimming mechanics, revealing how the animals achieve precise maneuverability. High‑speed video and fluid‑dynamic modeling showed that subtle fin curvature and timing generate lift and thrust efficiently....
Early Diagnosis Key to Managing Developmental Disorders
Early diagnosis is emerging as the linchpin for effective management of developmental disorders, with recent studies showing that interventions before age three dramatically improve functional outcomes. A multinational cohort of 12,000 infants revealed a 25% boost in adaptive behavior scores...
Single Enzyme Streamlines Production of All Four RNA Building Blocks
Researchers at the Institute of Science Tokyo have identified a novel enzyme, MAN PPK2, that universally phosphorylates all four RNA nucleotides into nucleoside triphosphates. The enzyme uses inexpensive polyphosphate as a phosphate donor, enabling a single‑step, low‑cost conversion of monophosphate and...
High Court Picked Hikma’s ‘Skinny Label’ Fight After Letting the Issue ‘Percolate’
The U.S. Supreme Court has agreed to hear Hikma Pharmaceuticals’ challenge over the use of “skinny labels,” a practice that allows generic manufacturers to market lower‑cost versions of drugs without copying the original brand’s full label. The case follows years...
Pharma Bets Big on AI Platforms with Flurry of New Year Deals
In early 2026 pharma giants Eli Lilly, GSK and Pfizer announced multi‑year AI platform agreements with start‑ups Chai Discovery, Noetik, and Boltz. Chai’s de novo antibody design model, Chai‑2, claims double‑digit success rates—over 100‑fold better than prior methods—while Noetik secured a $50 million...
Drugmakers Spent Less on Washington Lobbying in 2025's Final Quarter
The five largest biotech firms reduced their congressional lobbying expenditures in the fourth quarter of 2025, marking a modest decline from the previous quarter. Collectively, they spent roughly $45 million, down about 4 percent year‑over‑year. The dip reflects tighter corporate budgets and...
Resurrected Ancient Enzyme Offers New Window Into Early Earth and the Search for Life Beyond It
University of Wisconsin–Madison researchers have resurrected a 3.2‑billion‑year‑old nitrogenase enzyme and expressed it in modern microbes. Their experiments show the ancient enzyme produces isotopic signatures identical to those of contemporary nitrogenase, confirming the reliability of these signatures as biosignatures in...
FDA Lays Out New Path to Speed Development of Multiple Myeloma Drugs
The FDA released new guidance allowing accelerated approval of multiple myeloma therapies based on minimal residual disease (MRD) or complete response endpoints. This shift lets sponsors use single‑arm or randomized trials focused on deep molecular responses, reducing the need for...
Corcept's Drug Extends Patients' Lives in Key Ovarian Cancer Study
Corcept Therapeutics announced that its experimental drug, when combined with standard chemotherapy, cut the risk of death by 35% for patients with a difficult-to‑treat form of ovarian cancer. The reduction was observed in a Phase 2 trial that met its primary...
Roche Boosts NC Factory Investment to $2B; Rentschler CEO Steps Down
Roche’s Genentech is increasing its capital outlay for the Holly Springs, North Carolina manufacturing complex to nearly $2 billion, marking a substantial boost to its U.S. production capacity. The additional funds will expand biologics and vaccine output, positioning the site as a...
Bristol Myers Signs Deal with Janux on T Cell Engager for $50M Upfront
Bristol Myers Squibb has entered a collaboration with San‑diego biotech Janux Therapeutics to develop a novel tumor‑activated T‑cell engager for solid cancers. The agreement provides Janux with a $50 million upfront cash payment, along with potential milestone and royalty payments. Janux...
DNA Nanodevices Reveal Acidic Nanolayer on Lysosome Surfaces in Live Cells
The research team introduced ratiometric DNA nanodevices anchored to the cytosolic leaflet of lysosomes, enabling direct measurement of juxta‑lysosomal pH in living cells. They discovered a previously unknown acidic nanolayer up to 21 nm thick on the outer lysosomal membrane, whose...
Battery-Free Nano-Sensors Could Pave the Way for Next-Generation Wearables
Researchers at the University of Surrey have created battery‑free nano‑sensors that generate power from tiny human motions. The ultra‑thin borophene‑embedded nanofiber mat, tested with 16 sensors, can monitor sleep patterns and subtle body movements without charging. The self‑powered triboelectric devices...
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments
Bristol Myers Squibb has signed a partnership with San Diego‑based Janux Therapeutics, committing up to $850 million in upfront payments and milestone funding to co‑develop a tumor‑activated immunotherapy. The investigational drug targets an undisclosed solid‑tumor antigen and employs a proprietary masking...
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
The FDA will begin accepting applications for its PreCheck pilot on Feb. 1, 2025, with a one‑month window to submit proposals for new domestic drug‑manufacturing facilities. The program, slated for a June 30 selection deadline, offers early regulatory feedback and a streamlined...
Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase III for Non-Opioid Pill
Lexicon Pharmaceuticals received FDA clearance to advance its non‑opioid analgesic pilavapadin into Phase III trials for diabetic peripheral neuropathic pain, following a smooth end‑of‑Phase II meeting. The agency raised no additional study requirements and agreed on a 12‑week, placebo‑controlled design using a...
‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s 'Anti-Science' Vaccine Policies
Pfizer CEO Albert Bourla publicly denounced U.S. Health Secretary Robert F. Kennedy Jr. as "anti‑science" for his vaccine rhetoric, a remark made at the World Economic Forum in Davos. Since Kennedy assumed the HHS role in February 2025, he has questioned...
